6 unknown. 6 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Unknown 6 |
| Phase 2 | 2 | Unknown 2 |
Follow Cystic Fibrosis: new trials by email Literature Review of Cystic Fibrosis trials Research Report on Cystic Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection Posaconazole 100 MG [Noxafil], Posaconazole 40 MG/ML - Cystic Fibrosis, Aspergillosis | Phase 2 / Phase 3 | Unknown | Bambino Gesù Hospital and Research Institute | 135 | 2021-04-22 | 2021-07-19 |
| Antibiotic Treatment Of Staphylococcus Aureus In Stable People With CF Cephalexin, Placebo - Cystic Fibrosis | Phase 3 | Unknown | University of British Columbia | 86 | 2020-07-27 | 2022-01-14 |
| RESULT: Reliable, Emergent Solution Using Liprotamase Treatment Liprotamase, porcine PERT - Exocrine Pancreatic Insufficiency, Cystic Fibrosis | Phase 3 | Unknown | Anthera Pharmaceuticals | 140 | 2017-04-28 | 2018-03-08 |
| Inhaled Glutathione (GSH) Versus Placebo in Cystic Fibrosis Inhaled Reduced Glutathione, Physiological solution - Cystic Fibrosis | Phase 3 | Unknown | Serafino A. Marsico | 150 | 2010-06-01 | 2011-10-13 |
| Study on the Efficacy of Slow Release Insulin in Cystic Fibrosis Patients With Glucide Intolerance and Clinical Decay Insulin - Cystic Fibrosis, Glucose Intolerance | Phase 3 | Unknown | Fondazione per la ricerca sulla Fibrosi Cistica | 70 | 2005-08-01 | 2009-08-04 |
| Treatment of Metabolic Alkalosis in Acute Exacerbations of Cystic Fibrosis Normal saline IV, salt tablets - Cystic Fibrosis | Phase 2 / Phase 3 | Unknown | Bayside Health | 40 | 2004-02-01 | 2005-09-14 |
Aspergillosis (1) · Exocrine Pancreatic Insufficiency (1) · Glucose Intolerance (1) · Hypercapnia (1) · Reinfection (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6) · Digestive System Diseases (6) · Genetic Diseases, Inborn (6) · Infant, Newborn, Diseases (6) · Lung Diseases (6) · Pancreatic Diseases (6) · Respiratory Tract Diseases (6) · Pathological Conditions, Signs and Symptoms (2) · Bacterial Infections and Mycoses (1) · Disease Attributes (1) · Glucose Metabolism Disorders (1) · Hyperglycemia (1) · Infections (1) · Metabolic Diseases (1) · Mycoses (1)
Cephalexin (1) · Insulin (1) · Insulin Glargine (1) · Salts (1) · Suspensions (1) · liprotamase lipase (1) · posaconazole (1)
Anthera Pharmaceuticals (1) · Bambino Gesù Hospital and Research Institute (1) · Bayside Health (1) · Fondazione per la ricerca sulla Fibrosi Cistica (1) · Serafino A. Marsico (1) · University of British Columbia (1)
Italy (3) · Spain (2) · United Kingdom (2) · Australia (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · Ireland (1) · Israel (1) · Lithuania (1) · Netherlands (1) · Poland (1)
Adilia Warris, Prof (1) · Jonathan Rayment, MDCM (1) · Laura Minicucci, MD (1) · Matthew T Naughton, MBBS, MD (1) · Monica Gangal (1) · Serafino A Marsico, PROF (1)
2019 (1)